ArcherDX snags $55 mln Series C

Boulder, Colorado-based ArcherDX Inc, a molecular diagnostics company, has secured $55 million in Series C financing.

Boulder, Colorado-based ArcherDX Inc, a molecular diagnostics company, has secured $55 million in Series C financing. Perceptive Advisors led the round.

Source: Press Release